Questions about this study?
The HopeStage team will email you.
TerminatedNCT01802515
A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
Medication studyAges 18–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- West HavenSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateDecember 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 14
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01802515
- Official title
Show the full official title
Atomoxetine Treatment for Opioid Maintained Cocaine Users
Recruitment & locations
TerminatedWest Haven
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Atomoxetine, low dose, Atomoxetine, high dose and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me